Researchers detail in ‘Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1,’ new data in head and neck cancer. According to recent research published in the journal Clinical Cancer Research, Transfer of prodrug activation systems into tumors by using replication-deficient viruses has been suggested to be an effective method for achieving high local and low systemic anticancer drug concentrations. Source: General Cancer News Articles Provided by Cancer Compass